上海药明生物技术有限公司 Wuxi Biologics
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership 2021-05-27 08:30
WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services 2021-05-14 08:30
WuXi Biologics Completed Three Acquisitions to Enhance its Global Network 2021-05-07 08:30
WuXi Biologics Receives 2021 Asia-Pacific Bioprocessing Excellence Award from IMAPAC 2021-04-13 17:00
WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA 2021-04-07 08:22
2020 Results Record High Despite a Challenging Year 2021-03-23 20:59
WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC Group 2021-03-18 08:59
WuXi Biologics to Acquire Biologics DS and DP Manufacturing Facilities from Pfizer China 2021-03-17 08:45
WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19 2021-03-16 16:30
Remote Pre-Approval Inspection Completed by EMA on WuXi Biologics' MFG4 Facility 2021-03-03 18:23
WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories 2021-02-25 08:00
The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics 2021-02-09 08:25
WuXi Biologics Receives GMP Certification from Brazil's ANVISA 2020-12-28 17:50
WuXi Biologics to Acquire Drug Substance Facility in Wuppertal, Germany from Bayer 2020-12-21 21:02
Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation 2020-12-02 19:00
WuXi Biologics Launched Biologics Integrated Innovation Center in Hangzhou 2020-11-20 16:30
WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa 2020-10-29 17:00
WuXi Biologics Records Excellent Interim Results 2020-08-18 00:51
WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer 2020-08-06 17:00
WuXi Biologics Awarded as "Most Honored Company" by Institutional Investor 2020-08-04 17:00
1 2 3 4 5 6 9